Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription 23.12.2024 1 Acta Ophthalmol 1 Am J Clin Nutr 1 Am J Epidemiol 1 Am J Kidney Dis 3 Am J Manag Care 3 Am J Ophthalmol 1 Ann Intern Med 2 Biochem Biophys Res Commun 1 BMC Ophthalmol 1 BMC Pediatr 1 BMJ 1 Circulation 15 Diabet Med 5 Diabetes 40 Diabetes Care 18 Diabetes Obes Metab 13 Diabetologia 4 Invest Ophthalmol Vis Sci 1 J Am Soc Nephrol 1 J Biol Chem 11 J Clin Endocrinol Metab 12 J Diabetes Complications 1 Kidney Int 3 Metabolism 1 Nature 2 Nutr Metab (Lond) 2 Ophthalmol Retina 11 PLoS One 1 Proc Natl Acad Sci U S A 1 Retina 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. GRZYBOWSKI A, Peeters F, Barao RC, Brona P, et al
   Evaluating the efficacy of AI systems in diabetic retinopathy detection: A comparative analysis of Mona DR and IDx-DR.
   Acta Ophthalmol. 2024 Dec 10. doi: 10.1111/aos.17428.
   PubMed         Abstract available
   
   

   
   Am J Clin Nutr

2. NEWTON RL JR, Katzmarzyk PT, Duru OK, Lee A, et al
   Increasing Diversity in the Nutrition, Obesity, and Diabetes Biomedical Workforce: The BRIDGES Consortium.
   Am J Clin Nutr. 2024 Dec 16:S0002-9165(24)01437.
   PubMed         Abstract available
   
   

   
   Am J Epidemiol

3. LEE M, Lakshminarayan K, Sedaghat S, Sabayan B, et al
   Population attributable fraction of total stroke associated with modifiable risk factors in the United States.
   Am J Epidemiol. 2024;193:1712-1719.
   PubMed         Abstract available
   
   

   
   Am J Kidney Dis

4. SHIN JI, Creon A, Carrero JJ
   Metformin in People With Diabetes and Advanced CKD: Should We Dare?
   Am J Kidney Dis. 2024 Dec 10:S0272-6386(24)01053.
   PubMed        
   
   

   
   Am J Manag Care

5. NEELAND IJ, Rajagopalan S
   A team-based approach to type 2 diabetes and cardiovascular care.
   Am J Manag Care. 2024;30.
   PubMed         Abstract available
   
   
6. HANDELSMAN Y
   Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic disease.
   Am J Manag Care. 2024;30.
   PubMed         Abstract available
   
   
7. FERDINAND KC
   An overview of cardiovascular-kidney-metabolic syndrome.
   Am J Manag Care. 2024;30.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

8. ANGUITA R, Desideri LF, Sivaprasad S, Wickam L, et al
   Reply to Comment on "Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy".
   Am J Ophthalmol. 2024 Dec 18:S0002-9394(24)00573.
   PubMed        
   
   
9. NISHIDA K, Maeno T, Nishida K
   Comment on, Early versus Delayed Vitrectomy for Vitreous Haemorrhage Secondary to Proliferative Diabetic Retinopathy.
   Am J Ophthalmol. 2024 Dec 17:S0002-9394(24)00572.
   PubMed        
   
   
10. HALLAJ S, Halfpenny W, Chuter BG, Weinreb RN, et al
    Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change.
    Am J Ophthalmol. 2024 Sep 3:S0002-9394(24)00392.
    PubMed         Abstract available
    
    

    
    Ann Intern Med

11. GIANCHANDANI R, Wei M, Demidowich A
    Management of Hyperglycemia in Hospitalized Patients.
    Ann Intern Med. 2024;177:ITC177-ITC192.
    PubMed         Abstract available
    
    

    
    Biochem Biophys Res Commun

12. ZHANG W, Zhang Y, Lv W, Kong Z, et al
    Isoquercitrin improves diabetes nephropathy by inhibiting the sodium-glucose co-transporter-2 pathway.
    Biochem Biophys Res Commun. 2024;744:151142.
    PubMed         Abstract available
    
    
13. ZHENG Y, Wu Z, Wei X, Zhang L, et al
    1,25(OH)2D3 promotes insulin secretion through the classical pyroptosis pathway in vitro and vivo.
    Biochem Biophys Res Commun. 2025;742:151058.
    PubMed         Abstract available
    
    

    
    BMC Ophthalmol

14. EREN OZDEMIR A
    Evaluation of the effect of melatonin treatment on telomere length of the retinal pigment epithelium in streptozotocin-induced diabetic rat model.
    BMC Ophthalmol. 2024;24:532.
    PubMed         Abstract available
    
    

    
    BMC Pediatr

15. YE L, Song X, Cui Y, Wu S, et al
    Sirolimus alleviated intractable diarrhea of IPEX syndrome: a case report and literature review.
    BMC Pediatr. 2024;24:806.
    PubMed         Abstract available
    
    

    
    BMJ

16. MOTTELSON M, Helby J, Nordestgaard BG, Ellervik C, et al
    Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: prospective cohort study.
    BMJ. 2024;387:e079147.
    PubMed         Abstract available
    
    

    
    Circulation

17. BIRKENFELD AL, Franks PW, Mohan V
    Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention.
    Circulation. 2024;150:1910-1912.
    PubMed        
    
    

    
    Diabet Med

18. SUN H, Deng W, Si S, Liu X, et al
    The impact of residual diabetic toe osteomyelitis at the conservative surgical resection margins on prognosis.
    Diabet Med. 2024 Dec 19:e15502. doi: 10.1111/dme.15502.
    PubMed         Abstract available
    
    
19. BARNARD-KELLY K, Marrero D, de Wit M, Pouwer F, et al
    Towards standardization of person-reported outcomes (PROs) in pediatric diabetes research: A consensus report.
    Diabet Med. 2024 Dec 17:e15484. doi: 10.1111/dme.15484.
    PubMed         Abstract available
    
    
20. JONES DL, Kusinski LC, Barker P, Burling K, et al
    Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes.
    Diabet Med. 2024 Dec 17:e15476. doi: 10.1111/dme.15476.
    PubMed         Abstract available
    
    
21. SEIDU S, Avery L, Bell H, Brown P, et al
    Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus.
    Diabet Med. 2024 Dec 15:e15500. doi: 10.1111/dme.15500.
    PubMed         Abstract available
    
    
22. KARALLIEDDE J, Hills CE
    A special issue on from bench to bedside: An integrated and multidisciplinary approach to tackling diabetic kidney disease.
    Diabet Med. 2024 Dec 15:e15501. doi: 10.1111/dme.15501.
    PubMed        
    
    
23. JONES A, Staniszewska A, Hinchliffe R
    Diabetic foot disease: Assessing adherence of national acute and screening referral pathways with NICE guidelines.
    Diabet Med. 2024 Dec 14:e15478. doi: 10.1111/dme.15478.
    PubMed        
    
    
24. PHAM CT, Ali A, Churilov L, Baqar S, et al
    The association between glycaemic variability and sleep quality and quantity in adults with type 1 and type 2 diabetes: A systematic review.
    Diabet Med. 2024 Dec 11:e15485. doi: 10.1111/dme.15485.
    PubMed         Abstract available
    
    
25. ZHOU Y, Wheeler BJ, Boucsein A, Styles SE, et al
    Use of Freestyle Libre 2.0 in children with type 1 diabetes mellitus and elevated HbA(1c): Extension phase results after a 12-week randomized controlled trial.
    Diabet Med. 2024 Dec 10:e15494. doi: 10.1111/dme.15494.
    PubMed         Abstract available
    
    
26. SMITH TA, Venkatesh N, Roem K, Lu JC, et al
    OptimAAPP, a smartphone insulin dose calculator for carbohydrate, fat, and protein: A cross-over, randomised controlled trial in adolescents and adults with type 1 diabetes using multiple daily injection therapy.
    Diabet Med. 2024 Dec 9:e15487. doi: 10.1111/dme.15487.
    PubMed         Abstract available
    
    
27. HUSSAIN S, Hope O, Dhatariya K, Fayers K, et al
    Analysis of attitudes towards and experiences with physician Associates in Diabetes and Endocrinology from a survey of Association of British Clinical Diabetologists members.
    Diabet Med. 2024 Dec 8:e15493. doi: 10.1111/dme.15493.
    PubMed        
    
    
28. ZHYZHNEUSKAYA SV, Al-Mrabeh AH, Peters C, Barnes AC, et al
    Clinical utility of liver function tests for resolution of metabolic dysfunction-associated steatotic liver disease after weight loss in the Diabetes Remission Clinical Trial.
    Diabet Med. 2024 Dec 8:e15462. doi: 10.1111/dme.15462.
    PubMed         Abstract available
    
    
29. PATTON SR, Bergford S, Gal RL, Calhoun P, et al
    Fear of hypoglycemia relates to glycemic levels during and after real-world physical activity in adolescents with type 1 diabetes.
    Diabet Med. 2024 Dec 8:e15482. doi: 10.1111/dme.15482.
    PubMed         Abstract available
    
    
30. GOLUBIC R, Mumbole H, Ismail MH, Choo A, et al
    Glucocorticoid treatment and new-onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Diabet Med. 2024 Dec 6:e15475. doi: 10.1111/dme.15475.
    PubMed         Abstract available
    
    
31. BENTON M, Waheed N, Ismail K
    From the shadows: A qualitative study of fathers' perspectives and experiences of their partner's gestational diabetes mellitus and its implications.
    Diabet Med. 2024 Dec 6:e15488. doi: 10.1111/dme.15488.
    PubMed         Abstract available
    
    
32. ROIKJER J, Monteiro-Soares M, Walton D, Iacopi E, et al
    External validation of the DIAFORA system to predict lower-extremity amputations in a prospective Danish cohort.
    Diabet Med. 2025;42:e15443.
    PubMed         Abstract available
    
    

    
    Diabetes

33. D'ALESSIO DA, Kahn SE
    The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.
    Diabetes. 2025;74:1-3.
    PubMed        
    
    
34. LI A, Gong S, Yu C, Pei P, et al
    Phenotypic vs. Genetic Mismatch of BMI and Type 2 Diabetes: Evidence from Two Perspective Cohort Studies.
    Diabetes. 2024 Dec 10:db240736. doi: 10.2337/db24-0736.
    PubMed         Abstract available
    
    
35. LU J, Ni J, Su H, He X, et al
    One-Hour Postload Glucose Is a More Sensitive Marker of Impaired beta-Cell Function Than Two-Hour Postload Glucose.
    Diabetes. 2025;74:36-42.
    PubMed         Abstract available
    
    
36. RUSSO GT, Nicolucci A, Lucisano G, Rossi MC, et al
    When Does Metabolic Memory Start? Insights From the Association of Medical Diabetologists Annals Initiative on Stringent HbA1c Targets.
    Diabetes. 2025;74:75-81.
    PubMed         Abstract available
    
    
37. XING X, Xu S, Wang Y, Shen Z, et al
    Evaluating the Causal Effect of Circulating Proteome on Glycemic Traits: Evidence From Mendelian Randomization.
    Diabetes. 2025;74:108-119.
    PubMed         Abstract available
    
    

    
    Diabetes Care

38. BILAL A
    Understanding Diabetes Overtreatment in Older Adults: Are We at an Intersection?
    Diabetes Care. 2025;48:47-49.
    PubMed        
    
    
39. WHEELER BJ, Boucsein A
    Automated Insulin Delivery for People With Type 1 Diabetes and High HbA1c: Is It Time?
    Diabetes Care. 2025;48:50-51.
    PubMed        
    
    
40. D'ALESSIO DA, Kahn SE
    The Development of Glucagon-Like Peptide 1 as a Therapeutic: The Triumph of the Lasker Award for Obesity Is a Victory for Diabetes Research.
    Diabetes Care. 2025;48:3-5.
    PubMed        
    
    
41. PATEL SA
    Diabetes Complications in the U.S.: Following the Data to Guide Comprehensive Action.
    Diabetes Care. 2025;48:15-17.
    PubMed        
    
    
42. CHEN ZZ, Lu C, Isganaitis E
    Response to Comment on Chen et al. Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes. Diabetes Care 2024;47:1597-1607.
    Diabetes Care. 2025;48:e7.
    PubMed        
    
    
43. WANG R, Kyi M, Fourlanos S
    Comment on Lee et al. Empowering Hospitalized Patients With Diabetes: Implementation of a Hospital-Wide CGM Policy With EHR-Integrated Validation for Dosing Insulin. Diabetes Care 2024;47:1838-1845.
    Diabetes Care. 2025;48:e8-e9.
    PubMed        
    
    
44. PAGE B
    About the Editor: Matthew C. Riddle, MD: Managing Type 2 Diabetes With Glucose-Lowering Agents in Combination.
    Diabetes Care. 2025;48:2.
    PubMed        
    
    
45. LIU Y, Li T
    Comment on Chen et al. Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes. Diabetes Care 2024;47:1597-1607.
    Diabetes Care. 2025;48:e6.
    PubMed        
    
    
46. DAYA NR, Fang M, Wang D, Valint A, et al
    Glucose Abnormalities Detected by Continuous Glucose Monitoring in Very Old Adults With and Without Diabetes.
    Diabetes Care. 2024 Dec 20:dc241990. doi: 10.2337/dc24-1990.
    PubMed         Abstract available
    
    
47. ECHERMAN D, Smart CE, Collins K, King BR, et al
    Diagnostic Outcomes of Elevated Transglutaminase IgA Antibodies in Children With Newly Diagnosed Type 1 Diabetes.
    Diabetes Care. 2024 Dec 20:dc241554. doi: 10.2337/dc24-1554.
    PubMed        
    
    
48. LAFFEL LM, Sherr JL, Liu J, Wolf WA, et al
    Limitations in Achieving Glycemic Targets From CGM Data and Persistence of Severe Hypoglycemia in Adults With Type 1 Diabetes Regardless of Insulin Delivery Method.
    Diabetes Care. 2024 Dec 19:dc241474. doi: 10.2337/dc24-1474.
    PubMed         Abstract available
    
    
49. KLEIN KR, Lingvay I, Tuttle KR, Flythe JE, et al
    Glycemic Management and Individualized Diabetes Care in Dialysis-Dependent Kidney Failure.
    Diabetes Care. 2024 Dec 18:dci240081. doi: 10.2337/dci24-0081.
    PubMed         Abstract available
    
    
50. BOWMAN P, Shepherd MH, Flanagan SE, Tonks J, et al
    Improved Neurodevelopment Following In Utero Sulfonylurea Exposure in a Patient With KCNJ11 Permanent Neonatal Diabetes: Future Implications for Targeted Treatment During Pregnancy.
    Diabetes Care. 2024 Dec 17:dc241862. doi: 10.2337/dc24-1862.
    PubMed        
    
    
51. WALKER AF, Haller MJ, Addala A, Filipp SL, et al
    Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People.
    Diabetes Care. 2024 Dec 17:dc242100. doi: 10.2337/dc24-2100.
    PubMed         Abstract available
    
    
52. WANG Y, Guo D, Xia Y, Hu M, et al
    Effect of Community-Based Integrated Care for Patients With Diabetes and Depression (CIC-PDD) in China: A Pragmatic Cluster-Randomized Trial.
    Diabetes Care. 2024 Dec 16:dc241593. doi: 10.2337/dc24-1593.
    PubMed         Abstract available
    
    
53. SHIN A, Shin JY, Kang EH
    Risk of Nephrolithiasis Associated With SGLT2 Inhibitors Versus DPP4 Inhibitors Among Patients With Type 2 Diabetes: A Target Trial Emulation Study.
    Diabetes Care. 2024 Dec 12:dc241652. doi: 10.2337/dc24-1652.
    PubMed         Abstract available
    
    
54. OHKUMA T, Harris K, Woodward M, Hamet P, et al
    Intensive Glucose Lowering and Its Effects on Vascular Events and Death According to Age at Diagnosis and Duration of Diabetes: The ADVANCE Trial.
    Diabetes Care. 2024 Dec 11:dc241516. doi: 10.2337/dc24-1516.
    PubMed         Abstract available
    
    
55. EJIMOGU E, Echouffo-Tcheugui J, Fang M, Selvin E, et al
    Use of High-Risk Glucose-Lowering Agents in Older U.S. Adults With Diabetes and Cognitive Impairment.
    Diabetes Care. 2024 Dec 9:dc242178. doi: 10.2337/dc24-2178.
    PubMed        
    
    
56. 
    9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
57. 
    4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed        
    
    
58. 
    Disclosures: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed        
    
    
59. 
    2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
60. 
    15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
61. 
    Summary of Revisions: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed        
    
    
62. 
    5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
63. 
    Introduction and Methodology: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed        
    
    
64. 
    6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
65. 
    14. Children and Adolescents: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
66. 
    17. Diabetes Advocacy: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
67. 
    7. Diabetes Technology: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
68. 
    13. Older Adults: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
69. 
    8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
70. 
    11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
71. 
    1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
72. 
    12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
73. 
    16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
74. 
    3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
75. 
    10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025.
    Diabetes Care. 2025;48.
    PubMed         Abstract available
    
    
76. MITTENDORFER B, Patterson BW, Smith GI, Yoshino M, et al
    Effects of Obesity and Hyperglycemia on Postprandial Insulin-Mediated and Non-Insulin-Mediated Glucose Disposal.
    Diabetes Care. 2024 Nov 5:dc241280. doi: 10.2337/dc24-1280.
    PubMed         Abstract available
    
    
77. ABRAHAM MB, Smith GJ, Dart J, Clarke A, et al
    Glycemic and Psychosocial Outcomes of Advanced Hybrid Closed-Loop Therapy in Youth With High HbA1c: A Randomized Clinical Trial.
    Diabetes Care. 2025;48:67-75.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

78. GUO L, Chen L, Zhao F, Liu X, et al
    Improved glycaemic control in people with type 2 diabetes initiating or switching to IDegAsp in a real-world setting in China.
    Diabetes Obes Metab. 2024 Dec 20. doi: 10.1111/dom.16139.
    PubMed         Abstract available
    
    
79. SOHN M, Park YH, Lim S
    Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Diabetes Obes Metab. 2024 Dec 20. doi: 10.1111/dom.16131.
    PubMed         Abstract available
    
    
80. WANG Y, Lu J, Yu J, Ni J, et al
    Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes.
    Diabetes Obes Metab. 2024 Dec 18. doi: 10.1111/dom.16143.
    PubMed         Abstract available
    
    
81. MOURA FA, Kamanu FK, Wiviott SD, Giugliano RP, et al
    Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers.
    Diabetes Obes Metab. 2024 Dec 18. doi: 10.1111/dom.16123.
    PubMed         Abstract available
    
    
82. HERMAN WH, Kuo S, Zhang P
    A comment on "Metformin in the Diabetes Prevention Program 3-year trial: The cost-effectiveness that never was".
    Diabetes Obes Metab. 2024 Dec 18. doi: 10.1111/dom.16124.
    PubMed        
    
    
83. CHEN L, Wan H, Han J, Yang C, et al
    Efficacy and safety of switching to insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin in China: A post hoc subpopulation analysis of the INITIATION study.
    Diabetes Obes Metab. 2024 Dec 18. doi: 10.1111/dom.16144.
    PubMed         Abstract available
    
    
84. GARGOURI I, Charfi H, Belabed W, Outenah C, et al
    Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control-IQ and MiniMed 780G according to patient characteristics.
    Diabetes Obes Metab. 2024 Dec 17. doi: 10.1111/dom.16118.
    PubMed         Abstract available
    
    
85. YANG S, Yuan Y, Zhang B, Wu T, et al
    Identification of adipose tissue-derived exosomal microRNA as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: Triangulating evidence from Mendelian randomization and multicentre population studies.
    Diabetes Obes Metab. 2024 Dec 17. doi: 10.1111/dom.16121.
    PubMed         Abstract available
    
    
86. HUANG CC, Hsu RF, Chen WM, Shia BC, et al
    Metformin lowers risk of hearing loss and mortality in type 2 diabetes.
    Diabetes Obes Metab. 2024 Dec 17. doi: 10.1111/dom.16128.
    PubMed         Abstract available
    
    
87. ERWIN AP, Patrie JT, Horton WB
    Heart failure phenotypes in people with type 1 diabetes.
    Diabetes Obes Metab. 2024 Dec 17. doi: 10.1111/dom.16133.
    PubMed        
    
    
88. MOURA FS, Amaral MJM, Lima LCV, Souza M, et al
    Prevalence of MASLD in children and adolescents with type 1 diabetes: A meta-analysis.
    Diabetes Obes Metab. 2024 Dec 17. doi: 10.1111/dom.16125.
    PubMed        
    
    
89. YU YH, Platt RW, Reynier P, Yu OHY, et al
    Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population-based cohort study.
    Diabetes Obes Metab. 2024 Dec 16. doi: 10.1111/dom.16115.
    PubMed         Abstract available
    
    
90. SSEMMONDO E, Shah N, Newham M, Rigby A, et al
    Effect of introduction of intermittently scanned continuous glucose monitoring on glycaemic control in individuals living with type 2 diabetes mellitus treated with non-insulin therapies-A randomised controlled trial.
    Diabetes Obes Metab. 2024 Dec 11. doi: 10.1111/dom.16116.
    PubMed         Abstract available
    
    
91. WANG Y, Wen Q, Lu Y, Yang J, et al
    Identifying subgroups benefiting from intensive glycaemic treatment to improve renal outcomes in type 2 diabetes: Insights from the ACCORD trial.
    Diabetes Obes Metab. 2024 Dec 9. doi: 10.1111/dom.16111.
    PubMed         Abstract available
    
    
92. AJJAN RA
    The clinical importance of measuring glycaemic variability: Utilising new metrics to optimise glycaemic control.
    Diabetes Obes Metab. 2024;26 Suppl 7.
    PubMed         Abstract available
    
    
93. BENHALIMA K, Yamamoto JM
    Use of continuous glucose monitoring and hybrid closed-loop therapy in pregnancy.
    Diabetes Obes Metab. 2024;26 Suppl 7:74-91.
    PubMed         Abstract available
    
    
94. KONG YW, Morrison D, Lu JC, Lee MH, et al
    Continuous ketone monitoring: Exciting implications for clinical practice.
    Diabetes Obes Metab. 2024;26 Suppl 7.
    PubMed         Abstract available
    
    
95. ANANDHAKRISHNAN A, Hussain S
    Automating insulin delivery through pump and continuous glucose monitoring connectivity: Maximizing opportunities to improve outcomes.
    Diabetes Obes Metab. 2024;26 Suppl 7:27-46.
    PubMed         Abstract available
    
    

    
    Diabetologia

96. NADEAU KJ, Arslanian SA, Bacha F, Caprio S, et al
    Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06327.
    PubMed         Abstract available
    
    
97. COLE A, Weight N, Misra S, Grapsa J, et al
    Correction: Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study.
    Diabetologia. 2024 Dec 20. doi: 10.1007/s00125-024-06337.
    PubMed        
    
    
98. SHAPIRO MR, Tallon EM, Brown ME, Posgai AL, et al
    Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06339.
    PubMed         Abstract available
    
    
99. WERNROTH ML, Kennedy B, Fall K, Nguyen D, et al
    Bereavement and type 1 diabetes in childhood: a register-based cohort study in Sweden.
    Diabetologia. 2024 Dec 19. doi: 10.1007/s00125-024-06340.
    PubMed         Abstract available
    
    
100. BITARAFAN V, Anjom-Shoae J, Rezaie P, Fitzgerald PCE, et al
     Dose-related effects of intraduodenal quinine on plasma glucose, glucoregulatory hormones and gastric emptying of a nutrient drink, and energy intake, in men with type 2 diabetes: a double-blind, randomised, crossover study.
     Diabetologia. 2024 Dec 18. doi: 10.1007/s00125-024-06344.
     PubMed         Abstract available
     
     
101. KRISTENSEN FPB, Domazet SL, Nielsen JS, Stidsen JV, et al
     Elevated risk of infection in individuals with hyperinsulinaemic type 2 diabetes: a Danish 12 year cohort study.
     Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06342.
     PubMed         Abstract available
     
     
102. PERKINS BA, Turner LV, Riddell MC
     Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes.
     Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06317.
     PubMed        
     
     
103. SMEIJER JD, de Vries ST, Kohan DE, Hou FF, et al
     Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.
     Diabetologia. 2024 Dec 11. doi: 10.1007/s00125-024-06326.
     PubMed         Abstract available
     
     
104. DE VRIES ST, Pena MJ, Tye SC, Peters SAE, et al
     Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials.
     Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06325.
     PubMed         Abstract available
     
     
105. MOSER O, Zaharieva DP, Adolfsson P, Battelino T, et al
     The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPA
     Diabetologia. 2024 Dec 10. doi: 10.1007/s00125-024-06308.
     PubMed         Abstract available
     
     
106. CHIMIENTI R, Torchio S, Siracusano G, Zamarian V, et al
     A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome.
     Diabetologia. 2025;68:128-151.
     PubMed         Abstract available
     
     
107. FU Q, Dai H, Shen S, He Y, et al
     Interactions of genes with alcohol consumption affect insulin sensitivity and beta cell function.
     Diabetologia. 2025;68:116-127.
     PubMed         Abstract available
     
     
108. AHN M, Dhawan S, McCown EM, Garcia PA, et al
     Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis.
     Diabetologia. 2025;68:152-165.
     PubMed         Abstract available
     
     

     
     Invest Ophthalmol Vis Sci

109. VAUGHAN M, Tay N, Kalitzeos A, Kane T, et al
     Changes in Waveguiding Cone Photoreceptors and Color Vision in Patients With Diabetes Mellitus.
     Invest Ophthalmol Vis Sci. 2024;65:28.
     PubMed         Abstract available
     
     
110. YANG Y, Fan C, Zhang Y, Kang T, et al
     Untargeted Metabolomics Reveals the Role of Lipocalin-2 in the Pathological Changes of Lens and Retina in Diabetic Mice.
     Invest Ophthalmol Vis Sci. 2024;65:19.
     PubMed         Abstract available
     
     
111. LAI C, Su T, Cao J, Li Q, et al
     Retinal Neurovascular Impairment in Full-Course Diabetic Retinopathy: The Guangdong Diabetic Retinopathy Multiple-Omics Study.
     Invest Ophthalmol Vis Sci. 2024;65:20.
     PubMed         Abstract available
     
     
112. YU Y, Cui S, He Y, Zhang J, et al
     Early Diabetic Retinopathy Evaluation With OCTA: A Study on Vascular Branching and Fragmentation.
     Invest Ophthalmol Vis Sci. 2024;65:21.
     PubMed         Abstract available
     
     

     
     J Am Soc Nephrol

113. MEHTA SS, Surapaneni AL, Pandit K, Xu Y, et al
     Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease.
     J Am Soc Nephrol. 2024 Nov 27. doi: 10.1681/ASN.0000000585.
     PubMed        
     
     

     
     J Biol Chem

114. HUANG Y, Zhang Y, Liu Y, Jin Y, et al
     PRDX4 mitigates diabetic retinopathy by inhibiting reactive gliosis, apoptosis, ER stress, oxidative stress, and mitochondrial dysfunction in Muller cells.
     J Biol Chem. 2024 Dec 18:108111. doi: 10.1016/j.jbc.2024.108111.
     PubMed         Abstract available
     
     

     
     J Clin Endocrinol Metab

115. YANG X, Peng J, Sun F, Wu P, et al
     Renal function and risk of gestational diabetes mellitus: the potential mediating role of carnitine metabolites.
     J Clin Endocrinol Metab. 2024 Dec 18:dgae881. doi: 10.1210.
     PubMed         Abstract available
     
     
116. BHATTACHARYA S, Nagendra L, Dutta D, Kamrul-Hasan ABM, et al
     Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
     J Clin Endocrinol Metab. 2024 Dec 17:dgae878. doi: 10.1210.
     PubMed         Abstract available
     
     
117. BASKOY G, Peterson R, Kempenich J, Triplitt C, et al
     Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Type 2 Diabetes Patients: A Pilot Study.
     J Clin Endocrinol Metab. 2024 Dec 17:dgae872. doi: 10.1210.
     PubMed         Abstract available
     
     
118. YOUSIF MF, Dolak KD, Adhikari S, White PC, et al
     A nested case-control study of adverse outcomes in children with diabetic ketoacidosis.
     J Clin Endocrinol Metab. 2024 Dec 6:dgae848. doi: 10.1210.
     PubMed         Abstract available
     
     
119. YUEN L, Wong V, Immanuel J, Hague WM, et al
     Ethnic Differences in Characteristics of Women Diagnosed with Early Gestational Diabetes: Findings from the TOBOGM Study.
     J Clin Endocrinol Metab. 2024 Dec 6:dgae838. doi: 10.1210.
     PubMed         Abstract available
     
     
120. FRANKS PW, Rich SS, Linder B, Zaghloul NA, et al
     A Research Roadmap to Address the Heterogeneity of Diabetes and Advance Precision Medicine.
     J Clin Endocrinol Metab. 2024 Dec 6:dgae844. doi: 10.1210.
     PubMed         Abstract available
     
     
121. LIN YK, Ye W, Hepworth E, Rickels MR, et al
     Impaired Awareness and Symptomatology of Hypoglycemia in Adults with Type 1 Diabetes using Continuous Glucose Monitoring.
     J Clin Endocrinol Metab. 2024 Dec 5:dgae846. doi: 10.1210.
     PubMed         Abstract available
     
     
122. GENOSAR R, Coman MM, Herold KC
     Reversing diabetes with your own cells: Closer to the dream.
     J Clin Endocrinol Metab. 2024 Dec 13:dgae851. doi: 10.1210.
     PubMed        
     
     
123. YOSHIMURA K, Hirota Y, Saito S, Nishikage S, et al
     Prediction of insulin requirements by explainable machine learning for individuals with type 1 diabetes.
     J Clin Endocrinol Metab. 2024 Dec 11:dgae863. doi: 10.1210.
     PubMed         Abstract available
     
     
124. JALLEH RJ, Plummer MP, Marathe CS, Umapathysivam MM, et al
     Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
     J Clin Endocrinol Metab. 2024;110:1-15.
     PubMed         Abstract available
     
     
125. KAMPMANN U, Suder LB, Nygaard M, Geiker NRW, et al
     Pre-pregnancy and gestational interventions to prevent childhood obesity.
     J Clin Endocrinol Metab. 2024 Oct 14:dgae724. doi: 10.1210.
     PubMed         Abstract available
     
     

     
     J Diabetes Complications

126. HAUGE SC, Hjortkjaer HO, Persson F, Theilade S, et al
     Bone mineral density and the risk of kidney disease in patients with type 1 diabetes.
     J Diabetes Complications. 2024;39:108927.
     PubMed         Abstract available
     
     
127. ADDINGTON KS, Kristiansen M, Hempler NF, Frimodt-Moller M, et al
     Incidence of early-onset type 2 diabetes and sociodemographic predictors of complications: A nationwide registry study.
     J Diabetes Complications. 2024;39:108942.
     PubMed         Abstract available
     
     
128. REN R, Pei Y, Kong L, Shi Y, et al
     The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease.
     J Diabetes Complications. 2024;39:108932.
     PubMed         Abstract available
     
     
129. ZHENG Z, Cao B, Ke J, Zhao D, et al
     The effect of long-term glycemic burden on the incidence of diabetic foot ulcers: A retrospective study.
     J Diabetes Complications. 2024;39:108901.
     PubMed         Abstract available
     
     
130. LI X, Huang B, Liu Y, Wang M, et al
     Uric acid in diabetic microvascular complications: Mechanisms and therapy.
     J Diabetes Complications. 2024;39:108929.
     PubMed         Abstract available
     
     
131. ALFADDA AA, Alqutub AN, Sherbeeni SM, Aldosary AS, et al
     Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD.
     J Diabetes Complications. 2024;39:108910.
     PubMed         Abstract available
     
     
132. GEORGE BL, Perez AM, Rodriguez P, Parekh P, et al
     The association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier.
     J Diabetes Complications. 2024;39:108931.
     PubMed         Abstract available
     
     
133. OSMAN AAM, Seres-Bokor A, Ducza E
     Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications.
     J Diabetes Complications. 2024;39:108941.
     PubMed         Abstract available
     
     
134. HEINRICH NS, Pedersen RP, Vestergaard MB, Lindberg U, et al
     Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease.
     J Diabetes Complications. 2024;39:108923.
     PubMed         Abstract available
     
     
135. YARIBEYGI H, Kashian K, Moghaddam KI, Karim SR, et al
     Hepatic effects of GLP-1 mimetics in diabetic milieu: A mechanistic review of involved pathways.
     J Diabetes Complications. 2025;39:108928.
     PubMed         Abstract available
     
     
136. SIDRA FNU, Agarwal S, Lockhart Pastor P, Xie D, et al
     Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy.
     J Diabetes Complications. 2025;39:108925.
     PubMed         Abstract available
     
     
137. LEE H, Hartfield PJ, Thorgerson A, Sinson GP, et al
     Cambridge risk score, new hyperglycemia, and complications in surgical patients without diabetes.
     J Diabetes Complications. 2025;39:108926.
     PubMed         Abstract available
     
     

     
     Kidney Int

138. FOLESTAD E, Mehlem A, Ning FC, Oosterveld T, et al
     Vascular endothelial growth factor B-mediated fatty acid flux in the adipose-kidney axis contributes to lipotoxicity in diabetic kidney disease.
     Kidney Int. 2024 Dec 15:S0085-2538(24)00872-X. doi: 10.1016/j.kint.2024.
     PubMed         Abstract available
     
     

     
     Metabolism

139. KIM JS, Jun JH, Lee J, Park S, et al
     HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy.
     Metabolism. 2024 Dec 15:156108. doi: 10.1016/j.metabol.2024.156108.
     PubMed         Abstract available
     
     
140. LUO YY, Ruan CS, Zhao FZ, Yang M, et al
     ZBED3 exacerbates hyperglycemia by promoting hepatic gluconeogenesis through CREB signaling.
     Metabolism. 2025;162:156049.
     PubMed         Abstract available
     
     
141. DENG X, Tang C, Fang T, Li T, et al
     Disruption of branched-chain amino acid homeostasis promotes the progression of DKD via enhancing inflammation and fibrosis-associated epithelial-mesenchymal transition.
     Metabolism. 2025;162:156037.
     PubMed         Abstract available
     
     

     
     Nature

142. ABBOTT A
     Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson's disease could soon be here.
     Nature. 2025;637:18-20.
     PubMed        
     
     

     
     Nutr Metab (Lond)

143. ICHIKAWA T, Hashimoto Y, Igarashi Y, Kawai S, et al
     Association between gut microbiota and ultra-processed foods consumption among the patients with type 2 diabetes: a cross-sectional study.
     Nutr Metab (Lond). 2024;21:110.
     PubMed         Abstract available
     
     
144. BAHADORAN Z, Mirmiran P, Ghasemi A
     Type 2 diabetes-related sarcopenia: role of nitric oxide.
     Nutr Metab (Lond). 2024;21:107.
     PubMed         Abstract available
     
     

     
     Ophthalmol Retina

145. DUFFY BV, Castellanos-Canales D, Decker NL, Lee HJ, et al
     Foveal avascular zone enlargement correlates with visual acuity decline in patients with diabetic retinopathy.
     Ophthalmol Retina. 2024 Dec 13:S2468-6530(24)00592.
     PubMed         Abstract available
     
     
146. MUAYAD J, Loya A, Hussain ZS, Lee DH, et al
     Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus.
     Ophthalmol Retina. 2024 Dec 5:S2468-6530(24)00582.
     PubMed         Abstract available
     
     

     
     PLoS One

147. SULTANA KAKOLY N, Hasan SMK, Hoque MM, Ratul RH, et al
     Sociodemographic factors, clinical characteristics, outcomes and short-term follow-up in COVID-19 patients with new onset hyperglycemia and pre-existing diabetes on admission in a tertiary-care hospital in Bangladesh.
     PLoS One. 2024;19:e0311508.
     PubMed         Abstract available
     
     
148. XI X, Liu X, Chen Q, Ma J, et al
     Acteoside relieves diabetic retinopathy through the inhibition of Muller cell reactive hyperplasia by regulating TXNIP and mediating Kir4.1 channels in a PI3K/Akt-dependent manner.
     PLoS One. 2024;19:e0312565.
     PubMed         Abstract available
     
     
149. KOMATSU K, Sano K, Fukai K, Nakagawa R, et al
     Standardized evaluation of diabetic retinopathy using artificial intelligence and its association with metabolic dysfunction-associated steatotic liver disease in Japan: A cross-sectional study.
     PLoS One. 2024;19:e0315752.
     PubMed         Abstract available
     
     
150. NOPARATAYAPORN P, Thavorncharoensap M, Chaikledkaew U, Looareesuwan P, et al
     Cost-utility and budget impact analysis of laparoscopic bariatric surgery for obesity with Type II Diabetes Mellitus in Thailand.
     PLoS One. 2024;19:e0315336.
     PubMed         Abstract available
     
     
151. LEMOINE E, Dusenne M, Schuers M
     Glycemic control and bacterial infectious risk in type 2 diabetes: A retrospective cohort from a primary care database.
     PLoS One. 2024;19:e0314287.
     PubMed         Abstract available
     
     
152. NWAOHA IO, Balibuno AA, Ibrahim N
     Factors associated with the uptake and utilisation of diabetic retinopathy screening services in sub-Saharan Africa: A scoping review.
     PLoS One. 2024;19:e0315367.
     PubMed         Abstract available
     
     
153. CURTIS D
     Analysis of rare coding variants in 470,000 exome-sequenced subjects characterises contributions to risk of type 2 diabetes.
     PLoS One. 2024;19:e0311827.
     PubMed         Abstract available
     
     
154. LANGE FERREIRA C, Donetto S, Habte-Asres H, Govindan J, et al
     SHINE study: Developing an intervention for safe hospital insulin use for older or frail adults with diabetes undergoing surgical hospital admission: Study protocol.
     PLoS One. 2024;19:e0315387.
     PubMed         Abstract available
     
     
155. CHEN X, Huang H, Li J, Zhang Y, et al
     Association of iron homeostasis-related gene polymorphisms with pregnancy and neonatal outcomes in patients with gestational diabetes mellitus.
     PLoS One. 2024;19:e0312180.
     PubMed         Abstract available
     
     
156. LIN H, Gao Z, Ni H, Li J, et al
     Exploring the link between dietary thiamine and type 2 diabetes mellitus risk in US adults aged 45 years and older: Insights from a cross-sectional investigation.
     PLoS One. 2024;19:e0313114.
     PubMed         Abstract available
     
     
157. RIBEIRO DAS, de Araujo AC, do Nascimento PKDSB, da Rocha IMG, et al
     Effects of probiotic supplementation on the anthropometric nutritional status of patients with type 2 Diabetes mellitus: A systematic review and meta-analysis protocol.
     PLoS One. 2024;19:e0314971.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

158. KITAMURA RA, Hummel D, Ustione A, Piston DW, et al
     Dual role of neuroplastin in pancreatic beta cells: Regulating insulin secretion and promoting islet inflammation.
     Proc Natl Acad Sci U S A. 2024;121:e2411234121.
     PubMed         Abstract available
     
     

     
     Retina

159. VIDAL-OLIVER L, Spissinger S, Almeida EH, Garzone D, et al
     Prevalence and associated factors of choroidal caverns in patients with type 2 diabetes mellitus.
     Retina. 2024 Dec 3. doi: 10.1097/IAE.0000000000004365.
     PubMed         Abstract available
     
     

     
     Transplantation

160. MATTKE J, Eaton A, Wijkstrom M, Witkowski P, et al
     Islet Isolation Outcomes in Patients Undergoing Total Pancreatectomy With Islet Autotransplantation in the POST Consortium.
     Transplantation. 2025;109:207-216.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.